BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17379818)

  • 1. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stracke CP; Katoh M; Wiethoff AJ; Parsons EC; Spangenberg P; Spüntrup E
    Stroke; 2007 May; 38(5):1476-81. PubMed ID: 17379818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
    Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
    Spuentrup E; Wiethoff AJ; Parsons EC; Spangenberg P; Stracke CP
    Eur J Radiol; 2010 Jun; 74(3):445-52. PubMed ID: 19394183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Mahnken AH; Günther RW; Buecker A
    Am J Respir Crit Care Med; 2005 Aug; 172(4):494-500. PubMed ID: 15937292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
    Spuentrup E; Buecker A; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Weisskoff RM; Graham PB; Manning WJ; Günther RW
    Circulation; 2005 Mar; 111(11):1377-82. PubMed ID: 15738354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M; Haage P; Wiethoff AJ; Günther RW; Bücker A; Tacke J; Spuentrup E
    Invest Radiol; 2009 Mar; 44(3):146-50. PubMed ID: 19151606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E; Fausten B; Kinzel S; Wiethoff AJ; Botnar RM; Graham PB; Haller S; Katoh M; Parsons EC; Manning WJ; Busch T; Günther RW; Buecker A
    Circulation; 2005 Jul; 112(3):396-9. PubMed ID: 16009790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
    Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
    Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
    Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.
    Spuentrup E; Botnar RM; Wiethoff AJ; Ibrahim T; Kelle S; Katoh M; Ozgun M; Nagel E; Vymazal J; Graham PB; Günther RW; Maintz D
    Eur Radiol; 2008 Sep; 18(9):1995-2005. PubMed ID: 18425519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging.
    Sirol M; Aguinaldo JG; Graham PB; Weisskoff R; Lauffer R; Mizsei G; Chereshnev I; Fallon JT; Reis E; Fuster V; Toussaint JF; Fayad ZA
    Atherosclerosis; 2005 Sep; 182(1):79-85. PubMed ID: 16115477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular MRI of intracranial thrombus in a rat ischemic stroke model.
    Uppal R; Ay I; Dai G; Kim YR; Sorensen AG; Caravan P
    Stroke; 2010 Jun; 41(6):1271-7. PubMed ID: 20395615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI diagnosis of dural sinus - Cortical venous thrombosis: Immediate post-contrast 3D GRE T1-weighted imaging versus unenhanced MR venography and conventional MR sequences.
    Sari S; Verim S; Hamcan S; Battal B; Akgun V; Akgun H; Celikkanat S; Tasar M
    Clin Neurol Neurosurg; 2015 Jul; 134():44-54. PubMed ID: 25938564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K; Koerner S; Looby RJ; Kolodziej AF; Zech SG; Deng Q; Chasse JM; McMurry TJ; Caravan P
    J Am Chem Soc; 2008 May; 130(18):6025-39. PubMed ID: 18393503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of T2*-weighted gradient-echo MRI for the diagnosis of cerebral venous sinus thrombosis.
    Ihn YK; Jung WS; Hwang SS
    Clin Imaging; 2013; 37(3):446-50. PubMed ID: 23068055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.
    Andia ME; Saha P; Jenkins J; Modarai B; Wiethoff AJ; Phinikaridou A; Grover SP; Patel AS; Schaeffter T; Smith A; Botnar RM
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1193-1198. PubMed ID: 24723557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis.
    Fellner FA; Fellner C; Aichner FT; Mölzer G
    Eur J Radiol; 2005 Nov; 56(2):235-9. PubMed ID: 15967621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.